» Articles » PMID: 36128152

Cerebral Toxoplasmosis in a Patient with Combined Variable Immunodeficiency

Overview
Journal Surg Neurol Int
Specialty Neurology
Date 2022 Sep 21
PMID 36128152
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cerebral toxoplasmosis is an opportunistic infection in patients but has rarely been described in the setting of compromised humoral immunodeficiency. Prompt diagnosis and treatment of the infection is critical in the care of these patients. Medical management is the mainstay of treatment of the infection. There have been very few reports of surgical management of cerebral toxoplasmosis.

Case Description: We describe the case of a 40-year-old male who presented with headache, memory deficits, weight loss, and left-sided weakness in the setting of a known but undiagnosed brain lesion identified 1 month prior. Imaging demonstrated a right basal ganglia lesion which was initially presumed to be malignancy. On further workup including a positive serum test and biopsy including polymerase chain reaction analysis, diagnosis was confirmed as toxoplasmosis. On further investigation, he was found to have deficiencies in immunoglobulins consistent with common variable immunodeficiency (CVID). The patient underwent craniotomy with surgical debulking as repeat imaging showed increased size of mass with new satellite lesions and worsening hydrocephalus.

Conclusion: Cerebral toxoplasmosis is an important differential to consider in cases of intracerebral lesions and should not necessarily be excluded in the absence of compromised cellular immunity. In cases where there is no immunocompromised state and malignancy cannot immediately be established, CVID should be considered as an etiology. Due to the subtlety of CVID diagnosis, careful attention should be paid to history taking and workup for CVID should be considered as soon as possible. Surgical removal of these lesions in conjunction with medications is an effective treatment option.

Citing Articles

Recurrent ocular toxoplasmosis is associated with interferon-gamma deficiency possibly due to genetic origin.

Hautala N, Joensuu M, Paakkola T, Glumoff V, Kettunen K, Saarela J BMJ Open Ophthalmol. 2024; 9(1).

PMID: 39277179 PMC: 11404243. DOI: 10.1136/bmjophth-2024-001769.

References
1.
Eggers C, Vortmeyer A, Emskotter T . Cerebral toxoplasmosis in a patient with the acquired immunodeficiency syndrome presenting as obstructive hydrocephalus. Clin Neuropathol. 1995; 14(1):51-4. View

2.
Sell M, Klingebiel R, Di Iorio G, Sampaolo S . Primary cerebral toxoplasmosis: a rare case of ventriculitis and hydrocephalus in AIDS. Clin Neuropathol. 2005; 24(3):106-11. View

3.
Malphettes M, Gerard L, Carmagnat M, Mouillot G, Vince N, Boutboul D . Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009; 49(9):1329-38. DOI: 10.1086/606059. View

4.
Vidal J . HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease. J Int Assoc Provid AIDS Care. 2019; 18:2325958219867315. PMC: 6900575. DOI: 10.1177/2325958219867315. View

5.
Zhang J, Liu X, Fu K, Xu C, Gong R, Liu L . Diagnostic Value and Safety of Stereotactic Biopsy in Acquired Immune Deficiency Syndrome Patients with Intracranial Lesions: Systematic Review and Meta-Analysis. World Neurosurg. 2016; 98:790-799.e13. DOI: 10.1016/j.wneu.2016.11.151. View